Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial

OBJECTIVE: Specific lipid molecular changes leading to type 2 diabetes (T2D) are largely unknown. We assessed lipidome factors associated with future occurrence of T2D in a population at high cardiovascular risk. RESEARCH DESIGN AND METHODS: We conducted a case-cohort study nested within the PREDIME...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Care
Hlavní autoři: Razquin, Cristina, Toledo, Estefanía, Clish, Clary B., Ruiz-Canela, Miguel, Dennis, Courtney, Corella, Dolores, Papandreou, Christopher, Ros, Emilio, Estruch, Ramon, Guasch-Ferré, Marta, Gómez-Gracia, Enrique, Fitó, Montserrat, Yu, Edward, Lapetra, José, Wang, Dong, Romaguera, Dora, Liang, Liming, Alonso-Gómez, Angel, Deik, Amy, Bullo, Mónica, Serra-Majem, Lluis, Salas-Salvadó, Jordi, Hu, Frank B., Martínez-González, Miguel A.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Diabetes Association 2018
Témata:
Cardiovascular and Metabolic Risk
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6245212/
https://ncbi.nlm.nih.gov/pubmed/30327364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-0840
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky